Literature DB >> 6991401

Human monocyte-derived chemotactic factor for granulocytes.

T Tono-Oka, M Nakayama, S Matsumoto.   

Abstract

Production of the chemotactic factor for granulocytes (CFG) by human mononuclear cells was studied using the agarose plate method. CFG was produced by mononuclear cells placed in an agarose well, and a chemotactic gradient was formed in the surrounding area. The degree of CFG production by mononuclear cells was estimated by the chemotactic response of indicator granulocytes which were placed in separated agarose wells in the same dish. CFG production was observed after 3 h culture in a well where LPS or anti-beta 2 microglobulin serum stimulated mononuclear cells were placed. CFG did not show chemotactic activity for monocytes. PHA, Con A, PWM and Sepharose-Protein A failed to activate mononuclear cells to produce significant amounts of CFG compared with non-stimulated cells. There was a dose-response relationship between the chemotactic activity of the CFG produced and the number of phagocytic mononuclear cells in well culture. Thus it was concluded that the CFG-producing cells are not lymphocytes, but phagocytic mononuclear cells or monocytes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991401      PMCID: PMC1458019     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  The role of macrophages in the production of lymphokines by T and B lymphocytes.

Authors:  S M Wahl; J M Wilton; D L Rosenstreich; J J Oppenheim
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  The elaboration of leukotactic mediators during the interaction between parental-type lymphocytes and F1 hybrid cells.

Authors:  P A Ward; A Volkman
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

3.  Purification of lymphocytes.

Authors:  K Tebbi
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

4.  The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.

Authors:  P A Ward; H G Remold; J R David
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

5.  Cell migration inhibition factor released by antigen from human peripheral lymphocytes.

Authors:  D E Thor; R E Jureziz; S R Veach; E Miller; S Dray
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

6.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

7.  Leukotactic factor produced by sensitized lymphocytes.

Authors:  P A Ward; H G Remold; J R David
Journal:  Science       Date:  1969-03-07       Impact factor: 47.728

8.  Characterization of chemotactic activity produced in vivo by a cell-mediated immune reaction in the guinea pig.

Authors:  A E POSTLETHWAITE; R Snyderman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

9.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

10.  Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors.

Authors:  S M Wahl; G M Iverson; J J Oppenheim
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

View more
  4 in total

1.  Inhibition of the release of a neutrophil chemotactic factor from macrophages partially explains the anti-inflammatory action of glucocorticoids.

Authors:  F Q Cunha; A T Cacini; S H Ferreira
Journal:  Agents Actions       Date:  1986-01

2.  Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity.

Authors:  G E de Souza; S H Ferreira
Journal:  Agents Actions       Date:  1985-10

3.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

4.  A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.

Authors:  J Van Damme; J Van Beeumen; G Opdenakker; A Billiau
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.